The store will not work correctly when cookies are disabled.
2-Methyl-N'-(4-methylbenzylidene)imidazo[1,2-a]pyridine-3-carbohydrazide
ID: ALA3310311
PubChem CID: 9585812
Max Phase: Preclinical
Molecular Formula: C17H16N4O
Molecular Weight: 292.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(/C=N/NC(=O)c2c(C)nc3ccccn23)cc1
Standard InChI: InChI=1S/C17H16N4O/c1-12-6-8-14(9-7-12)11-18-20-17(22)16-13(2)19-15-5-3-4-10-21(15)16/h3-11H,1-2H3,(H,20,22)/b18-11+
Standard InChI Key: BVPFUKZKGPSCKH-WOJGMQOQSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
7.5479 -4.4295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3447 -4.2159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5583 -3.4191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9749 -2.8357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1780 -3.0492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9645 -3.8461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1733 -5.1646 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3585 -5.0355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2294 -4.2207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4943 -3.8461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4512 -3.0222 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7799 -4.2586 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0654 -3.8461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3509 -4.2586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6365 -3.8461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9220 -4.2586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2075 -3.8461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2075 -3.0211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9220 -2.6086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6365 -3.0211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4930 -2.6086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7751 -5.6189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
6 9 1 0
1 7 2 0
12 13 1 0
10 11 2 0
10 12 1 0
9 10 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
18 21 1 0
13 14 2 0
8 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 292.34 | Molecular Weight (Monoisotopic): 292.1324 | AlogP: 2.72 | #Rotatable Bonds: 3 |
Polar Surface Area: 58.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.79 | CX Basic pKa: 4.32 | CX LogP: 2.31 | CX LogD: 2.31 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.60 | Np Likeness Score: -2.48 |
References
1. Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.. (2014) Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors., 22 (15): [PMID:24953948] [10.1016/j.bmc.2014.05.038] |